BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 16262633)

  • 1. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation.
    Liu F; Grundke-Iqbal I; Iqbal K; Gong CX
    Eur J Neurosci; 2005 Oct; 22(8):1942-50. PubMed ID: 16262633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTDP-17 missense mutations site-specifically inhibit as well as promote dephosphorylation of microtubule-associated protein tau by protein phosphatases of HEK-293 cell extract.
    Han D; Paudel HK
    Neurochem Int; 2009 Jan; 54(1):14-27. PubMed ID: 18992292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A.
    Zhou XW; Gustafsson JA; Tanila H; Bjorkdahl C; Liu R; Winblad B; Pei JJ
    Neurobiol Dis; 2008 Sep; 31(3):386-94. PubMed ID: 18586097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over activation of hippocampal serine/threonine protein phosphatases PP1 and PP2A is involved in lead-induced deficits in learning and memory in young rats.
    Rahman A; Khan KM; Al-Khaledi G; Khan I; Al-Shemary T
    Neurotoxicology; 2012 Jun; 33(3):370-83. PubMed ID: 22387731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dephosphorylation of tau by protein phosphatase 5: impairment in Alzheimer's disease.
    Liu F; Iqbal K; Grundke-Iqbal I; Rossie S; Gong CX
    J Biol Chem; 2005 Jan; 280(3):1790-6. PubMed ID: 15546861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperphosphorylation of tau and protein phosphatases in Alzheimer disease.
    Liu F; Liang Z; Gong CX
    Panminerva Med; 2006 Jun; 48(2):97-108. PubMed ID: 16953147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of protein phosphatase-2A from human brain structures, immunocytological localization and activities towards dephosphorylation of the Alzheimer type hyperphosphorylated tau.
    Tsujio I; Zaidi T; Xu J; Kotula L; Grundke-Iqbal I; Iqbal K
    FEBS Lett; 2005 Jan; 579(2):363-72. PubMed ID: 15642345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
    Walton JR
    J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine.
    Chohan MO; Khatoon S; Iqbal IG; Iqbal K
    FEBS Lett; 2006 Jul; 580(16):3973-9. PubMed ID: 16806196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early postnatal lead exposure induces tau phosphorylation in the brain of young rats.
    Rahman A; Khan KM; Al-Khaledi G; Khan I; Attur S
    Acta Biol Hung; 2012 Dec; 63(4):411-25. PubMed ID: 23134599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease of protein phosphatase 2A and its association with accumulation and hyperphosphorylation of tau in Down syndrome.
    Liang Z; Liu F; Iqbal K; Grundke-Iqbal I; Wegiel J; Gong CX
    J Alzheimers Dis; 2008 Apr; 13(3):295-302. PubMed ID: 18430997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta.
    Qian W; Shi J; Yin X; Iqbal K; Grundke-Iqbal I; Gong CX; Liu F
    J Alzheimers Dis; 2010; 19(4):1221-9. PubMed ID: 20308788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model.
    Corcoran NM; Martin D; Hutter-Paier B; Windisch M; Nguyen T; Nheu L; Sundstrom LE; Costello AJ; Hovens CM
    J Clin Neurosci; 2010 Aug; 17(8):1025-33. PubMed ID: 20537899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of choline transporter surface expression and phosphorylation by protein kinase C and protein phosphatase 1/2A.
    Gates J; Ferguson SM; Blakely RD; Apparsundaram S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):536-45. PubMed ID: 15064333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus.
    Vogelsberg-Ragaglia V; Schuck T; Trojanowski JQ; Lee VM
    Exp Neurol; 2001 Apr; 168(2):402-12. PubMed ID: 11259128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus.
    Zhang CE; Tian Q; Wei W; Peng JH; Liu GP; Zhou XW; Wang Q; Wang DW; Wang JZ
    Neurobiol Aging; 2008 Nov; 29(11):1654-65. PubMed ID: 17537547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lead dysregulates serine/threonine protein phosphatases in human neurons.
    Rahman A; Brew BJ; Guillemin GJ
    Neurochem Res; 2011 Feb; 36(2):195-204. PubMed ID: 21046238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of thromboxane receptor (TP) phosphorylation by protein phosphatase 1 (PP1) and PP2A.
    Spurney RF
    J Pharmacol Exp Ther; 2001 Feb; 296(2):592-9. PubMed ID: 11160648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PP2B isolated from human brain preferentially dephosphorylates Ser-262 and Ser-396 of the Alzheimer disease abnormally hyperphosphorylated tau.
    Rahman A; Grundke-Iqbal I; Iqbal K
    J Neural Transm (Vienna); 2006 Feb; 113(2):219-30. PubMed ID: 15959850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.